- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 7, 2026 | 158.29M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 158.48M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 126.66M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $597K |
| Capex | Q1 2026 · Mar 31, 2025 | $2K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$42.31M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$25.47M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $289.82M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $173.26M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $98.16M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $540.28M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $416.11M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $48.23M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $53.88M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $48.64M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $59.71M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $301.47M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $180.19M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $594.31M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $483.27M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.26 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.24 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.27 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.24 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $9.86M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $11.59M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $404K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $52K |
| Net Income | Q1 2026 · Mar 31, 2026 | $41.74M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$30.52M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $96.76M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$27M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $505K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $442K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $353K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $293K |
| Revenue | Q1 2026 · Mar 31, 2026 | $858K |
| Revenue | Q1 2026 · Mar 31, 2025 | $735K |